Abbott's HeartMate 3 LVAD is the only FDA-approved device of its kind currently available in the United States. Should reports of adverse events worry cardiologists? Or are they to be expected when treating such a vulnerable patient population?

While GLP-1 drugs were originally developed to treat diabetes, researchers keep finding additional ways these medications can potentially benefit patients.

Americans aren’t OK with generative healthcare AI that was developed without physicians and is sold by vendors without track records. 

Big as it is, the hospital piece represented just a 2.2% bump over 2021—a modest increase compared with 2021’s spike of 4.5% over 2020.

AI-based prediction models have shown significant promise, but many are still flawed in a way that limits their value. 

Prosecutors successfully argued that the patient would not have died if clinicians had ordered a routine CT exam. 

Hospitals should be making every effort to help sonographers deliver better, more accurate echocardiograms and improve the diagnosis of severe aortic stenosis. If you take care of your sonographers, your sonographers will take care of you. 

Valve-in-valve TAVR outperforms redo SAVR for the first six months after treatment, according to a new meta-analysis published in the American Journal of Cardiology. Then, however, things begin to shift.